BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

868 related articles for article (PubMed ID: 33723124)

  • 81. Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer.
    Afrin F; Chi M; Eamens AL; Duchatel RJ; Douglas AM; Schneider J; Gedye C; Woldu AS; Dun MD
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32340151
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cannabinoids and the expanded endocannabinoid system in neurological disorders.
    Cristino L; Bisogno T; Di Marzo V
    Nat Rev Neurol; 2020 Jan; 16(1):9-29. PubMed ID: 31831863
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Cannabis and cannabinoids as drugs].
    Khiabani HZ; Mørland J
    Tidsskr Nor Laegeforen; 2007 Mar; 127(5):579-82. PubMed ID: 17332810
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence.
    Chye Y; Kirkham R; Lorenzetti V; McTavish E; Solowij N; Yücel M
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):627-635. PubMed ID: 32948510
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis.
    Maayah ZH; Takahara S; Ferdaoussi M; Dyck JRB
    Inflamm Res; 2020 Jun; 69(6):549-558. PubMed ID: 32239248
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Pharmacology of cannabinoids.
    Grotenhermen F
    Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review.
    Dos Santos RG; Hallak JEC; Crippa JAS
    Adv Exp Med Biol; 2021; 1264():29-45. PubMed ID: 33332002
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?
    Maccarrone M; Maldonado R; Casas M; Henze T; Centonze D
    Expert Rev Clin Pharmacol; 2017 Apr; 10(4):443-455. PubMed ID: 28276775
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effect of combined doses of Δ
    Rock EM; Sullivan MT; Pravato S; Pratt M; Limebeer CL; Parker LA
    Psychopharmacology (Berl); 2020 Mar; 237(3):901-914. PubMed ID: 31897571
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Urinary cannabinoid mass spectrometry profiles differentiate dronabinol from cannabis use.
    Koch CD; Xu L; Curtis SA; Roberts JD; Bunch DR; El-Khoury JM
    Clin Chim Acta; 2020 Nov; 510():515-521. PubMed ID: 32795544
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cannabinoids in Treating Chemotherapy-Induced Nausea and Vomiting, Cancer-Associated Pain, and Tumor Growth.
    Bathula PP; Maciver MB
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203245
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?
    Khalid S; Almalki FA; Hadda TB; Bader A; Abu-Izneid T; Berredjem M; Elsharkawy ER; Alqahtani AM
    Curr Pharm Des; 2021; 27(13):1564-1578. PubMed ID: 33267756
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases.
    Maselli DB; Camilleri M
    Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1748-1758.e2. PubMed ID: 32673642
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Delta-9-tetrahydrocannabinol/cannabidiol (Sativex®): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis.
    Syed YY; McKeage K; Scott LJ
    Drugs; 2014 Apr; 74(5):563-78. PubMed ID: 24671907
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Role of the stress response and the endocannabinoid system in Δ
    DeVuono MV; La Caprara O; Sullivan MT; Bath A; Petrie GN; Limebeer CL; Rock EM; Hill MN; Parker LA
    Psychopharmacology (Berl); 2020 Jul; 237(7):2187-2199. PubMed ID: 32399633
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Efficacy of Cannabis and its Constituents in Disease Management: Insights from Clinical Studies.
    Vimal D; D'Souza LC; Rai V; Lal S; Sharma A; Gupta SC
    Curr Med Chem; 2023; 30(2):178-202. PubMed ID: 35619266
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.
    Davis MP
    Expert Opin Investig Drugs; 2008 Jan; 17(1):85-95. PubMed ID: 18095921
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Therapeutic potential of cannabinoid-based drugs.
    Klein TW; Newton CA
    Adv Exp Med Biol; 2007; 601():395-413. PubMed ID: 17713029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.